ReviewJournal of International Society of Preventive & Community Dentistry
Success Rate of Dental Implants in Patients with Autoimmune Disorders: A Systematic Review and Meta-Analysis.
Review in Journal of International Society of Preventive & Community Dentistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Autoimmune disorders may affect bone metabolism and tissue healing, potentially influencing dental implant outcomes. This systematic review and meta-analysis aimed to assess implant survival and success in patients with autoimmune diseases, with particular focus on marginal bone loss (MBL) and bleeding on probing (BOP). Materials and Methods: A comprehensive search of seven databases (PubMed, MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, and CINAHL) was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Fourteen observational studies including 2657 participants were included. Risk of bias was assessed using ROBINS-I and Newcastle-Ottawa scale. Meta-analyses were performed using a random-effects model. Results: Implant survival rates ranged from 76.4% to 100% across autoimmune conditions. No significant differences in MBL were observed for patients with type 1 diabetes or Sjögren's syndrome compared to controls, while rheumatoid arthritis (RA) patients showed significantly increased MBL [MD = 1.60 mm; 95% confidence intervals (CI) = 1.13-2.07; Conclusion: Dental implants demonstrate favorable survival in autoimmune patients, although RA and diabetes may increase MBL risk. Tailored treatment planning and follow-up are essential. Further high-quality studies are needed to confirm disease-specific risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.